Nuclear medicine is entering a new stage of development in Kazakhstan. Modern technologies now make it possible to detect dangerous diseases at an early stage and improve the treatment effectiveness, ...

Galiyeva also cited research comparing vegetarian, vegan and Mediterranean diets. The findings show that people following a ...

Editas Medicine announces advancements in in vivo CRISPR gene editing, optimizing costs, and reducing workforce while focusing on hematologic diseases. Editas Medicine, Inc. has announced a strategic ...

The longevity market is shifting from wellness to institutional healthcare, driven by AI, genomics, and regenerative medicine. Opportunities lie in integrated platforms for early risk detection and ...

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...

For most diseases, the challenge is not a lack of effort but the limits of existing tools and techniques. Just like every year, in 2025, we took another step toward pushing those limits further.

Over 500 in-person participants from 103 countries and more than 3000 virtual participants attended the fifth International Conference on Hybrid Imaging to strengthen the practice of nuclear medicine ...

When cholera ravaged Hamburg in 1892, politics — not science — drove the response. Over a century later, as we confront modern “epidemics” of obesity, chronic diseases, measles, and COVID, the ...

The healthcare industry is in the middle of a technology revolution, and at the same time, rising health care costs and an aging population are straining the world’s health care infrastructure. To ...